VA Study: Paxlovid Can Reduce Risk of ‘Long COVID’ by About 25%
New research from the VA determined that Paxlovid can reduce the risk of symptoms of long COVID by about 25%.
VA Frailty Index Associated With Survival in AML Patients
Acute myeloid leukemia (AML) is a particularly aggressive blood cancer that is most successfully treated with intensive chemotherapy. As the average age at diagnosis is 68, patients diagnosed with the disease are often too frail to withstand potentially curative treatment with induction regimens.
COVID-19 Minimally Affected Prescriptions, Hospital Admissions for Veterans with MM
As COVID-19 burst upon the world stage, medical care rapidly shifted from in-person visits to telemedicine consultations with varying results among patients with chronic conditions, cancer and other diseases that required regular and ongoing interaction with medical personnel.
Does Metformin Reduce Cancer Risk? The VA Weighs In
Over the last decade, a number of studies have examined a possible association between metformin use and reduction in the risk of cancer, with contradictory results.
VA Research Finds No Link Between First-Line ICIs, Embolism Risk
Retrospective studies suggest that receipt of immune checkpoint inhibitors (ICIs) may increase the risk of venous thromboembolism (VTE) compared to chemotherapy.